NewsRamp is a PR & Newswire Technology platform that enhances press release distribution by adapting content to align with how and where audiences consume information. Recognizing that most internet activity occurs outside of search, NewsRamp improves content discovery by programmatically curating press releases into multiple unique formats—news articles, blog posts, persona-based TLDRs, videos, audio, and Zero-Click content—and distributing this content through a network of news sites, blogs, forums, podcasts, video platforms, newsletters, and social media.
FAQ: NeuroOne Added to Russell Microcap Index
NeuroOne Medical Technologies Corporation has been added to the Russell Microcap Index as part of the 2026 reconstitution. This inclusion is significant because Russell indexes are widely used benchmarks, and membership can increase visibility among institutional investors.
The Russell Microcap Index consists of the smallest 1,000 securities in the Russell 2000 Index, plus the next 1,000 smallest eligible securities by market cap, representing micro-cap stocks.
Being added to the index increases NeuroOne's visibility among investment managers and institutional investors who use Russell indexes as benchmarks for active strategies and index funds, potentially attracting more investment.
NeuroOne was added effective when the US market opened on June 29, 2026, as part of the first 2026 Russell indexes reconstitution.
FTSE Russell determines membership primarily by objective, market-capitalization rankings and style attributes.
Membership in the Russell 3000 Index means automatic inclusion in the large-cap Russell 1000 Index or small-cap Russell 2000 Index, as well as the appropriate growth and value style indexes.
According to data as of end of June 2025, about $12.2 trillion in assets are benchmarked against the Russell US indexes.
NeuroOne is a medical technology company focused on improving surgical care for neurological disorders, marketing a minimally invasive electrode technology platform with four FDA-cleared product families for diagnostic and therapeutic functions.
More information is available on the FTSE Russell website in the 'Russell Reconstitution' section.
Investor relations contact is MZ Group – MZ North America at NMTC@mzgroup.us.